Pharmaceutical News

RSS

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

In a recent study published in the journal JAC-Antimicrobial Resistance, researchers investigated the trends in antibiotic prescriptions for upper respiratory tract infections to determine whether the decrease in in-person medical consultation appointments during the coronavirus disease 2019 (COVID-19) pandemic had an impact on the prescribing practices.

15 Feb 2023

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

A study conducted by US-based scientists claims that bivalent mRNA booster vaccines do not have any added benefits over monovalent booster vaccines in terms of inducing robust and durable neutralizing antibody response against omicron subvariants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

15 Feb 2023

As opioids mixed with animal tranquilizers arrive in Kensington, so do alarming health challenges

Many people living on the streets in Philadelphia's Kensington neighborhood — the largest open-air drug market on the East Coast — are in full-blown addiction, openly snorting, smoking, or injecting illicit drugs, hunched over crates or on stoops. Syringes litter sidewalks, and the stench of urine fouls the air.

15 Feb 2023

Armed with hashtags, these activists made insulin prices a presidential talking point

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who'd hacked their insulin pumps to automatically adjust the amount of insulin delivered.

15 Feb 2023

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

A meta-analysis on the long-term vaccine effectiveness of four COVID-19 vaccines.

14 Feb 2023

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, 44-month median, follow-up results from the Phase III CheckMate -9ER trial showing that Cabometyx® (cabozantinib) in combination with nivolumab provides survival and response rate benefits after three-years in the first-line treatment of advanced renal cell carcinoma (aRCC), compared to sunitinib.

From Ipsen 14 Feb 2023

High doses of cannabidiol may increase the effects of THC in edible cannabis products

Contrary to some common claims, a study led by Johns Hopkins Medicine researchers found that relatively high doses of cannabidiol (CBD) may increase the adverse effects of delta-9-tetrahydrocannabinol (THC), the main active ingredient in cannabis that can cause a mood alteration or a "high" sensation.

13 Feb 2023

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Researchers assess longitudinal alterations in SARS-CoV-2 IgG antibody titers after vaccination.

13 Feb 2023

Paxlovid can prevent hospitalization and death for patients infected with Omicron variants, study shows

Though many Coloradans are proceeding as though the COVID-19 pandemic is over, the virus continues to circulate, evolve and have an impact-;especially for older adults and those with underlying medical conditions.

13 Feb 2023

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

A new study in the journal Clinical Infectious Diseases aimed to determine the relative vaccine effectiveness (rVE) in three different recipient cohorts, those who received the Ad26.COV2.S vaccine followed by Ad26.COV2.S booster, those who received the Ad26.COV2.S vaccine followed by an mRNA booster, and those who received two doses of an mRNA vaccine followed by an mRNA booster.

12 Feb 2023

Study: Single dose of common antibiotic given during labor reduces the risk of maternal death or sepsis

Sepsis -; a severe infection in the body that can lead to tissue damage, organ failure, and death -; is among the top causes of maternal deaths worldwide, according to the World Health Organization (WHO).

10 Feb 2023

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

A new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs, according to a study published in the Journal of Urology.

10 Feb 2023

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Time is running out for free-to-consumer covid vaccines, at-home test kits, and even some treatments.

10 Feb 2023

Single dose of the antibiotic azithromycin decreases sepsis and death risk during childbirth

A single dose of the antibiotic azithromycin can help protect mothers from dangerous sepsis infections and death during vaginal childbirth, a sweeping new international study from a UVA Health scientist and his collaborators has found.

9 Feb 2023

Pegylated interferon lambda shows good efficacy against COVID-19

In a recent study published in The New England Journal of Medicine, researchers used the TOGETHER platform trial protocol to perform a phase III randomized controlled trial (RCT) to evaluate the effectiveness of pegylated interferon (IFN) lambda (λ) therapy in outpatients with coronavirus disease 2019 (COVID-19) in Canada and Brazil.

9 Feb 2023

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Researchers describe a novel SARS-CoV-2 spike protein component vaccine called MT-001.

9 Feb 2023

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

Heterologous vaccination improves the neutralization of SARS-CoV-2 Omicron sub-variants.

9 Feb 2023

FDA approves first drug for ESR1-mutated breast cancer

Dr. Rajkumar Lakshmanaswamy, Ph.D., Chair of the Department of Molecular and Translational Medicine, Center of Emphasis in Cancer and Dean of the L. Frederick Francis Graduate School of Biomedical Sciences at Texas Tech University Health Sciences Center El Paso is available to speak on the Federal Drug Administration's approval of the selective estrogen receptor (ER) degrader elacestrant (Orserdu).

9 Feb 2023

Preventing, diagnosing, and treating cardiovascular disease in women

An article published in the journal Medical Clinics of North America provides recent updates on cardiovascular disease prevention, diagnosis, and treatment in women.

8 Feb 2023

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

The recent JAMA Network Open study evaluated how the Chantix recall influenced prescribing varenicline and other nicotine dependency medications. For this cross-sectional study, a large US-based national cohort was used. All relevant data between January 1, 2021, and June 30, 2022, was obtained from the national pharmacy benefit database.

7 Feb 2023

Previous
1
...
58
59
60
61
62
63
64
...
1433
Next

Pharmaceutical News

The impact of COVID-19 on consultations and antibiotic prescribing for URTI in England

Bivalent and monovalent mRNA boosters induce similar antibody response against Omicron subvariants

As opioids mixed with animal tranquilizers arrive in Kensington, so do alarming health challenges

Armed with hashtags, these activists made insulin prices a presidential talking point

Meta-analysis showcases the long-term benefits of COVID-19 vaccines against hospitalization & death

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

High doses of cannabidiol may increase the effects of THC in edible cannabis products

Changes in SARS-CoV-2 antibody titers after COVID-19 vaccination

Paxlovid can prevent hospitalization and death for patients infected with Omicron variants, study shows

Vaccine efficacy and booster dose combinations among 18.9 million adults in the early phase of Omicron

Study: Single dose of common antibiotic given during labor reduces the risk of maternal death or sepsis

Mark Cuban's cost-plus drug pricing model offers significant savings to patients

Era of ‘free’ covid vaccines, test kits, and treatments is ending. Who will pay the tab now?

Single dose of the antibiotic azithromycin decreases sepsis and death risk during childbirth

Pegylated interferon lambda shows good efficacy against COVID-19

Novel COVID-19 protein component vaccine elicits durable immune response in rodents

Heterologous inactivated virus/mRNA booster strongly augments response to BF.7, BQ.1.1, and XBB.1

FDA approves first drug for ESR1-mutated breast cancer

Preventing, diagnosing, and treating cardiovascular disease in women

In the wake of Chantix's recall, Varenicline use for nicotine dependence dropped by 75%

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News